Kiora Pharmaceuticals Future Growth
Future criteria checks 2/6
Kiora Pharmaceuticals's earnings are forecast to decline at 6.1% per annum while its annual revenue is expected to grow at 25.9% per year. EPS is expected to grow by 66.8% per annum.
Key information
-6.1%
Earnings growth rate
66.8%
EPS growth rate
Pharmaceuticals earnings growth | 21.1% |
Revenue growth rate | 25.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 27 Mar 2024 |
Recent future growth updates
Recent updates
Kiora pharmaceuticals regains compliance with Nasdaq minimum bid price requirement
Oct 13Kiora Pharma announces 1-for-40 reverse stock split
Sep 26Kiora Pharmaceuticals reports 1H results
Aug 12Kiora gets US patent for KIO-201 use with antibiotics for eye wound healing
Jul 28Kiora Pharmaceuticals prices $5.2M underwritten public offering
Jul 22Kiora begins enrolling in phase 2 trial of wound healing eye drops KIO-201
Jul 05EyeGate Pharmaceuticals announces $8M private placement
Jan 06EyeGate surge in premarket as it acquires Panoptes Pharma for $4M
Dec 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -19 | N/A | N/A | 2 |
12/31/2025 | 2 | -15 | N/A | N/A | 2 |
12/31/2024 | 12 | -1 | N/A | N/A | 3 |
12/31/2023 | N/A | -13 | -10 | -10 | N/A |
9/30/2023 | N/A | -13 | -9 | -9 | N/A |
6/30/2023 | N/A | -12 | -10 | -10 | N/A |
3/31/2023 | N/A | -12 | -11 | -11 | N/A |
12/31/2022 | N/A | -14 | -10 | -10 | N/A |
9/30/2022 | N/A | -17 | -11 | -11 | N/A |
6/30/2022 | N/A | -15 | -11 | -11 | N/A |
3/31/2022 | N/A | -15 | -11 | -11 | N/A |
12/31/2021 | N/A | -14 | -11 | -11 | N/A |
9/30/2021 | 0 | -9 | -10 | -9 | N/A |
6/30/2021 | 0 | -8 | -9 | -9 | N/A |
3/31/2021 | 0 | -7 | -8 | -7 | N/A |
12/31/2020 | 0 | -7 | -7 | -7 | N/A |
9/30/2020 | N/A | -8 | -8 | -8 | N/A |
6/30/2020 | N/A | -10 | -8 | -8 | N/A |
3/31/2020 | N/A | -10 | -8 | -8 | N/A |
12/31/2019 | 3 | -7 | -8 | -8 | N/A |
9/30/2019 | 3 | -7 | -8 | -8 | N/A |
6/30/2019 | 3 | -7 | -9 | -8 | N/A |
3/31/2019 | 3 | -8 | -9 | -9 | N/A |
12/31/2018 | 2 | -11 | -11 | -11 | N/A |
9/30/2018 | 2 | -11 | -11 | -10 | N/A |
6/30/2018 | 1 | -12 | -10 | -10 | N/A |
3/31/2018 | 1 | -13 | -11 | -11 | N/A |
12/31/2017 | 0 | -13 | -7 | -6 | N/A |
9/30/2017 | 1 | -14 | N/A | -7 | N/A |
6/30/2017 | 1 | -13 | N/A | -7 | N/A |
3/31/2017 | 1 | -14 | N/A | -7 | N/A |
12/31/2016 | 1 | -13 | N/A | -8 | N/A |
9/30/2016 | 1 | -12 | N/A | -8 | N/A |
6/30/2016 | 0 | -10 | N/A | -6 | N/A |
3/31/2016 | N/A | -8 | N/A | -4 | N/A |
12/31/2015 | N/A | -17 | N/A | -4 | N/A |
9/30/2015 | N/A | -14 | N/A | -3 | N/A |
6/30/2015 | N/A | -13 | N/A | -3 | N/A |
3/31/2015 | N/A | -12 | N/A | -2 | N/A |
12/31/2014 | N/A | -2 | N/A | -1 | N/A |
9/30/2014 | N/A | -2 | N/A | -1 | N/A |
6/30/2014 | N/A | -3 | N/A | -2 | N/A |
3/31/2014 | N/A | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KPRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KPRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KPRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KPRX's revenue (25.9% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: KPRX's revenue (25.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KPRX's Return on Equity is forecast to be high in 3 years time